Developer docs
API playgroundTry for free, no card

Search company profiles

Medable

Full company profile

uuid00000o5

Namestring
Medable
Legal namestring
Medable Inc.
Websiteurl
medable.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Medable is a privately held clinical technology company that provides a unified, cloud-agnostic platform for decentralized clinical trials (DCT) and digital data capture, serving biopharmaceutical sponsors, contract research organizations (CROs), and emerging biopharma. Founded in 2012 and headquartered in Palo Alto, California, the company combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD and provisioned devices, and a 400+ instrument validated library across 120+ locales in a single platform deployed in roughly 70+ countries. Medable has grown its customer footprint to include 9 of the top 10 CROs, more than 45 emerging biopharma and biotech accounts, and named top-10 pharmaceutical sponsors across oncology, vaccine, and metabolic indications, with the platform used in nearly 400 trials serving over one million patients globally.

The company's technology stack layers agentic AI on top of its DCT platform through Medable Agent Studio, a no-code agentic AI environment purpose-built for GxP-regulated clinical development. Agent Studio hosts pre-built agents (CRA Agent for clinical monitoring, TMF Agent for trial master file automation, PI Summary Agent for investigator oversight, and DDF Agent for CDISC USDM 4.0 protocol transformation), connects to 30+ clinical and enterprise systems via MCP connectors, and operates over a clinical data ontology layer with human-in-the-loop controls and ALCOA+ audit trails. Revenue is generated primarily through enterprise SaaS subscriptions to the platform and its modules, hardware-based device logistics from six global depots, professional services via the Agentic Accelerator Program, and partnership economics through the CRO Partner Program and Google Cloud Marketplace. Pricing is quote-based with multi-year contracts and a self-serve pricing calculator for CROs; financial scale remains modest in disclosed terms with ~328 employees and reported 2024 revenue of $11.6M (third-party estimate) against approximately $506.6M of cumulative venture funding led by Blackstone Growth, GSR Ventures, and Tiger Global.

Short descriptiontext

Medable provides a unified, AI-enabled decentralized clinical trial platform with eCOA, eConsent, and pre-built clinical AI agents for biopharma sponsors, CROs, and emerging biotech across 70+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
decentralized clinical trials, clinical trial platform, electronic clinical outcomes, agentic AI clinical, electronic consent solutions
Industry2 codes
PRIMARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Decentralized Clinical Trial Software Platform
GTM motion5 records

Each record includes

Type, Description, Source

Revenue model4 records
1SaaS platform subscriptions (Agent Studio, eCOA+, Total Consent, Study Studio)
TypeSubscription Recurring
Description

Recurring subscription-based SaaS revenue from sponsors, CROs, and emerging biopharma for use of Medable's unified clinical trial platform, Agent Studio, eCOA+, Total Consent, Study Studio, and analytics. Pricing is quote-based with portal self-serve pricing tools for CROs; land-and-expand across portfolio studies is a key upsell lever.

medable.com
2Device logistics and provisioning
TypeHardware Sales
Description

Revenue from procurement, provisioning, and global delivery of clinical trial devices from six global depots, billed as one all-inclusive monthly rate per device.

medable.com
3Professional services: Agentic Accelerator Program, integration, change management
TypeProfessional Services
Description

High-touch enablement services including onboarding, integration support, governance, change management, dedicated AI clinical development experts, and forward-deployed engineers for sponsor and CRO customers adopting Agent Studio.

medable.com
4Data and evidence services (decentralized clinical trial data)
TypeData Monetisation
Description

Participation in the healthcare data monetization ecosystem, leveraging clinical trial data assets for analytics, real-world evidence, and evidence-generation partnerships.

openpr.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details2 tiers
1Quote-based SaaS subscription with CRO self-serve pricing calculator
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based pricing, not publicly disclosed. CRO Partner Program provides a self-serve pricing calculator to generate study-specific quotes in 30 seconds and transparent pricing tools.

medable.com
2Device logistics: one all-inclusive monthly rate
ModelUnit PricingBilling cadenceMonthly
Notes

Device procurement, provisioning, and global delivery from six depots priced at one all-inclusive monthly rate per device.

medable.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Agent Studio
Description

Medable's no-code agent-builder / agentic AI platform purpose-built for life sciences and clinical development.

medable.com
+3 more records
Core offering1 text field

Medable sells a unified, cloud-agnostic clinical trial platform that combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD/provisioned devices, sensors, and a no-code Study Studio, with an agentic AI layer (Agent Studio) of pre-built and custom AI agents for clinical monitoring, TMF, PI review, and digital data flow. The platform is purpose-built for decentralized clinical trials and sold primarily to biopharma sponsors and CROs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medable offers a unified clinical trial platform with a platform-plus-modules architecture: the Medable Platform serves as the core, integrating modules including eCOA+ (eCOA/ePRO), Total Consent (eConsent), TeleVisit, Medable Studio (no-code builder), and Medable AI capabilities, with built-in device logistics, BYOD support, and 24/7 global support. Layered on top is Agent Studio (Agent Platform), Medable's no-code agentic AI platform for clinical development, which hosts pre-built AI agents—CRA Agent (Clinical Monitoring), TMF Agent, PI Summary and Review Agent, and DDF Agent—plus a custom agent builder, all powered by MCP connectors to Veeva, Oracle, Medidata, MS 365, Snowflake, and BigQuery. Specialized offerings include the Oncology Solution and Vaccine Solution therapeutic-area packages, the CRO Partner Program, the Agentic Accelerator Program for AI deployment, and the Medable Academy DCT Foundations certification. The platform supports 70+ countries, 120+ locales, 400+ validated instruments, and integrates with enterprise systems while maintaining compliance with HIPAA, GDPR, FDA 21 CFR Part 11, and ICH E6(R2) GCP.

Product and service13 records
1Medable Platform
CategoryCore platform
2Agent Studio (Agent Platform)
CategoryAgentic AI platform
3CRA Agent (Clinical Monitoring Agent)
CategoryPre-built AI agent
4TMF Agent (eTMF Agent)
CategoryPre-built AI agent
5PI Summary and Review Agent
CategoryPre-built AI agent
6DDF Agent (Digital Data Flow Agent)
CategoryPre-built AI agent
7Medable Studio
CategoryNo-code eCOA builder
8eCOA+ (eCOA/ePRO)
CategoryElectronic Clinical Outcome Assessment
9Total Consent (eConsent)
CategoryElectronic Consent
10Medable AI
CategoryAI capability layer
11Oncology Solution
CategoryTherapeutic area solution
12Vaccine Solution
CategoryTherapeutic area solution
13Long-Term Follow-Up (LTFU) Model for Cell & Gene Therapy
CategoryTherapeutic area solution
Scale indicator21 records

Each record includes

Type, Value, Description, Source

Partnership21 partners
Strategic tierFlagshipTypeTechnology or Integration
Description

Joint partnership to deliver Medable's digital clinical trials technology on the Google Cloud Marketplace, enabling sponsors and CROs to procure Medable's solutions through existing Google Cloud relationships and accelerating enterprise adoption.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Alliance aimed at tackling diversity in clinical trials by expanding access to underserved populations through CVS Health's retail and care footprint. Operations are reported to span 60 countries alongside this collaboration.

3ICON
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Joint execution of a U.S. menopause clinical trial achieving 85% eConsent adoption across 1,200+ participants at 18 sites through tailored site-centric strategies, onboarding, and support.

medable.com
Strategic tierCoreTypeTechnology or Integration
Description

Partnership to optimize patient experience and improve access to clinical trials by integrating Pluto Health's patient-data services into Medable's evidence-generation platform.

Strategic tierCoreTypeTechnology or Integration
Description

Integration of the Masimo MightySat Rx pulse oximeter into Medable's evidence-generation platform, supporting eight pharmaceutical-sponsored clinical trials across 25 countries with over 3,000 patients in lung and breast cancer.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on the Medable Innovation Evidence Workshop series focused on DCT impact, adoption, and best practices; first workshop held November 19, 2025 in Boston with leaders from 20 pharma/biotech/CROs plus the FDA and Harvard MRCT.

Strategic tierModerateTypeStrategic or Co-development Partner
Description

Strategic partnership informing Medable's patient engagement and recruitment strategy alongside the Patient Caregiver Network (PCN) to improve clinical trial access, diversity, retention, and outcomes.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Host of Japan's Ubie Pharma Summit (May 13-14, 2026), where Medable CEO Michelle Longmire was featured as a guest speaker alongside Google and Mayo Clinic leaders at Japan's largest pharmaceutical conference focused on agentic AI in clinical research.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Listed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; supports enterprise consulting and implementation services alongside Medable's platform.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Listed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; CRO/biopharma services partner reselling and deploying Medable's digital trial platform.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Listed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; IT services and consulting partner supporting enterprise deployments.

12PwC
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Listed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; consulting partner supporting strategy, validation, and enterprise adoption.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Trusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Trusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.

Strategic tierCoreTypeTechnology or Integration
Description

Prebuilt MCP connector integration with Veeva (including Veeva Vault eTMF) listed as one of 30+ validated connectors that allow Medable agents to act across clinical and enterprise systems.

Strategic tierCoreTypeTechnology or Integration
Description

Prebuilt MCP connector integration with Oracle clinical systems as part of Medable's 30+ validated connector ecosystem, enabling agent interoperability.

Strategic tierCoreTypeTechnology or Integration
Description

Prebuilt MCP connector integration with Medidata as part of Medable's 30+ validated connector ecosystem for EDC and clinical data interoperability.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with Microsoft 365 collaboration tools (Teams) via Medable's MCP connectors so agents can surface insights and act across enterprise collaboration workflows.

Strategic tierCoreTypeTechnology or Integration
Description

Prebuilt connector to Snowflake as part of Medable's 30+ validated connectors, enabling clinical data interoperability across data warehouses.

Strategic tierModerateTypeTechnology or Integration
Description

Medable's TMF Agent integrates with existing eTMF systems including OpenText to automate 95% of manual TMF document workflows.

Strategic tierModerateTypeStrategic or Co-development Partner
Description

Featured in Medable's 'Sponsors talk AI' content series with Sanofi Global Head of Data Architecture, Utilization, and AI Engineering discussing AI integration in clinical trials and agentic AI adoption strategies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant life sciences cloud platform with Vault CTMS, eTMF, and eCDMS offerings that compete directly with Medable's clinical operations modules. Medable integrates with Veeva via MCP connectors, positioning it both as competitor and ecosystem partner.

TypeDirect peer
Description

Direct competitor in eCOA, EDC, and decentralized clinical trial technology, with Rave EDC and a broad sponsor/CRO install base. Medable's MCP connector to Medidata signals both direct competition and interoperability.

3Oracle Health Sciences (Clinical One)
TypeBroad incumbent
Description

Incumbent EDC, CTMS, and randomization provider for large pharma and CROs, competing with Medable on unified trial platforms. Medable's MCP connector to Oracle clinical systems confirms its role as competitor and partner.

TypeBroad incumbent
Description

Largest CRO with proprietary clinical technology (Orchestrated Clinical Trials) and an AI-driven eCOA/DCT stack. Competes with Medable across CRO channel, eCOA, and DCT deployments for biopharma sponsors.

TypeDirect peer
Description

Pioneer in decentralized clinical trial orchestration and direct competitor in DCT platform delivery for biopharma sponsors. Comparable in operating model as a DCT-native platform with eCOA, eConsent, and remote nurse capabilities.

TypeDirect peer
Description

Direct eCOA, eConsent, and patient engagement competitor formed by the merger of CRF Health and Bracket, serving the same top-tier biopharma and CRO customer base as Medable. Competes head-to-head in eCOA build libraries and translation capabilities.

TypeDirect peer
Description

Clinical trial endpoint technology provider offering eCOA, imaging, and cardiac safety solutions, with comparable device logistics and global trial expertise. Overlaps with Medable on eCOA, device provisioning, and regulatory-grade data capture.

TypeEmerging player
Description

DCT-focused clinical trial provider competing in decentralized trial design and eCOA, with stronger focus on fully decentralized operational delivery. Comparable in DCT-native positioning but smaller in eCOA library depth.

TypeEmerging player
Description

Cloud-native EDC and ePRO platform with growing DCT and eConsent capabilities, targeting emerging biopharma and academic sponsors. Competes with Medable in no-code study building and SMB-to-mid-market trial deployments.

TypeEmerging player
Description

Decentralized clinical trial software platform with site network, competing in DCT delivery for sponsors seeking software-plus-operations offerings. Comparable in DCT-native thesis but smaller scale than Medable's global deployment footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat8 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration14 records

Each record includes

Title, Type, Description, Source

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles27 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medable

Decentralized Clinical Trial Software Platformmedable.com

Medable provides a unified, AI-enabled decentralized clinical trial platform with eCOA, eConsent, and pre-built clinical AI agents for biopharma sponsors, CROs, and emerging biotech across 70+ countries.

What Medable does

Medable is a privately held clinical technology company that provides a unified, cloud-agnostic platform for decentralized clinical trials (DCT) and digital data capture, serving biopharmaceutical sponsors, contract research organizations (CROs), and emerging biopharma. Founded in 2012 and headquartered in Palo Alto, California, the company combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD and provisioned devices, and a 400+ instrument validated library across 120+ locales in a single platform deployed in roughly 70+ countries. Medable has grown its customer footprint to include 9 of the top 10 CROs, more than 45 emerging biopharma and biotech accounts, and named top-10 pharmaceutical sponsors across oncology, vaccine, and metabolic indications, with the platform used in nearly 400 trials serving over one million patients globally.

The company's technology stack layers agentic AI on top of its DCT platform through Medable Agent Studio, a no-code agentic AI environment purpose-built for GxP-regulated clinical development. Agent Studio hosts pre-built agents (CRA Agent for clinical monitoring, TMF Agent for trial master file automation, PI Summary Agent for investigator oversight, and DDF Agent for CDISC USDM 4.0 protocol transformation), connects to 30+ clinical and enterprise systems via MCP connectors, and operates over a clinical data ontology layer with human-in-the-loop controls and ALCOA+ audit trails. Revenue is generated primarily through enterprise SaaS subscriptions to the platform and its modules, hardware-based device logistics from six global depots, professional services via the Agentic Accelerator Program, and partnership economics through the CRO Partner Program and Google Cloud Marketplace. Pricing is quote-based with multi-year contracts and a self-serve pricing calculator for CROs; financial scale remains modest in disclosed terms with ~328 employees and reported 2024 revenue of $11.6M (third-party estimate) against approximately $506.6M of cumulative venture funding led by Blackstone Growth, GSR Ventures, and Tiger Global.

Medable firmographics

Firmographics
Name
Medable
Legal name
Medable Inc.
Website
https://medable.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
251–500 employees
Short description
Medable provides a unified, AI-enabled decentralized clinical trial platform with eCOA, eConsent, and pre-built clinical AI agents for biopharma sponsors, CROs, and emerging biotech across 70+ countries.
Ownership category
akta.pro rank

Medable industry classification

Industry
Product category
Decentralized Clinical Trial Software Platform
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Decentralized clinical trials
  • Clinical trial platform
  • Electronic clinical outcomes
  • Agentic AI clinical
  • Electronic consent solutions

Where Medable is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Medable business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS platform subscriptions (Agent Studio, eCOA+, Total Consent, Study Studio): Recurring subscription-based SaaS revenue from sponsors, CROs, and emerging biopharma for use of Medable's unified clinical trial platform, Agent Studio, eCOA+, Total Consent, Study Studio, and analytics. Pricing is quote-based with portal self-serve pricing tools for CROs; land-and-expand across portfolio studies is a key upsell lever.
  2. Device logistics and provisioning: Revenue from procurement, provisioning, and global delivery of clinical trial devices from six global depots, billed as one all-inclusive monthly rate per device.
  3. Professional services: Agentic Accelerator Program, integration, change management: High-touch enablement services including onboarding, integration support, governance, change management, dedicated AI clinical development experts, and forward-deployed engineers for sponsor and CRO customers adopting Agent Studio.
  4. Data and evidence services (decentralized clinical trial data): Participation in the healthcare data monetization ecosystem, leveraging clinical trial data assets for analytics, real-world evidence, and evidence-generation partnerships.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractQuote-based SaaS subscription with CRO self-serve pricing calculator
Unit PricingMonthlyDevice logistics: one all-inclusive monthly rate

Go-to-market motion5 records

Distribution channels1 record

Marketing channels8 records

Medable product offering

Product offering

Core offering

Medable sells a unified, cloud-agnostic clinical trial platform that combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD/provisioned devices, sensors, and a no-code Study Studio, with an agentic AI layer (Agent Studio) of pre-built and custom AI agents for clinical monitoring, TMF, PI review, and digital data flow. The platform is purpose-built for decentralized clinical trials and sold primarily to biopharma sponsors and CROs.

Product overview

Medable offers a unified clinical trial platform with a platform-plus-modules architecture: the Medable Platform serves as the core, integrating modules including eCOA+ (eCOA/ePRO), Total Consent (eConsent), TeleVisit, Medable Studio (no-code builder), and Medable AI capabilities, with built-in device logistics, BYOD support, and 24/7 global support. Layered on top is Agent Studio (Agent Platform), Medable's no-code agentic AI platform for clinical development, which hosts pre-built AI agents—CRA Agent (Clinical Monitoring), TMF Agent, PI Summary and Review Agent, and DDF Agent—plus a custom agent builder, all powered by MCP connectors to Veeva, Oracle, Medidata, MS 365, Snowflake, and BigQuery. Specialized offerings include the Oncology Solution and Vaccine Solution therapeutic-area packages, the CRO Partner Program, the Agentic Accelerator Program for AI deployment, and the Medable Academy DCT Foundations certification. The platform supports 70+ countries, 120+ locales, 400+ validated instruments, and integrates with enterprise systems while maintaining compliance with HIPAA, GDPR, FDA 21 CFR Part 11, and ICH E6(R2) GCP.

Differentiator

Problem solved

Functional benefit

Brands

  • Agent Studio: Medable's no-code agent-builder / agentic AI platform purpose-built for life sciences and clinical development.
  • Medable Studio
  • eCOA+
  • Total Consent

Products and services

  • Medable Platform
  • Agent Studio (Agent Platform)
  • CRA Agent (Clinical Monitoring Agent)
  • TMF Agent (eTMF Agent)
  • PI Summary and Review Agent
  • DDF Agent (Digital Data Flow Agent)
  • Medable Studio
  • eCOA+ (eCOA/ePRO)
  • Total Consent (eConsent)
  • Medable AI
  • Oncology Solution
  • Vaccine Solution
  • Long-Term Follow-Up (LTFU) Model for Cell & Gene Therapy

Companies that use Medable

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Medable technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration14 records

AI capability11 records

Feature13 records

Medable partnerships and signals

Strategic signal

Partnerships

21 partnerships are on record, tiered flagship, core and moderate.

  • Google CloudflagshipTechnology or IntegrationJoint partnership to deliver Medable's digital clinical trials technology on the Google Cloud Marketplace, enabling sponsors and CROs to procure Medable's solutions through existing Google Cloud relationships and accelerating enterprise adoption.
  • CVS HealthflagshipStrategic or Co-development PartnerAlliance aimed at tackling diversity in clinical trials by expanding access to underserved populations through CVS Health's retail and care footprint. Operations are reported to span 60 countries alongside this collaboration.
  • ICONflagshipStrategic or Co-development PartnerJoint execution of a U.S. menopause clinical trial achieving 85% eConsent adoption across 1,200+ participants at 18 sites through tailored site-centric strategies, onboarding, and support.
  • Pluto HealthcoreTechnology or IntegrationPartnership to optimize patient experience and improve access to clinical trials by integrating Pluto Health's patient-data services into Medable's evidence-generation platform.
  • MasimocoreTechnology or IntegrationIntegration of the Masimo MightySat Rx pulse oximeter into Medable's evidence-generation platform, supporting eight pharmaceutical-sponsored clinical trials across 25 countries with over 3,000 patients in lung and breast cancer.
  • Tufts Center for the Study of Drug Development (Tufts CSDD)coreStrategic or Co-development PartnerCollaboration on the Medable Innovation Evidence Workshop series focused on DCT impact, adoption, and best practices; first workshop held November 19, 2025 in Boston with leaders from 20 pharma/biotech/CROs plus the FDA and Harvard MRCT.
  • Rare Patient VoicemoderateStrategic or Co-development PartnerStrategic partnership informing Medable's patient engagement and recruitment strategy alongside the Patient Caregiver Network (PCN) to improve clinical trial access, diversity, retention, and outcomes.
  • Ubie (Ubie Pharma Summit, Japan)coreGTM or Marketing PartnerHost of Japan's Ubie Pharma Summit (May 13-14, 2026), where Medable CEO Michelle Longmire was featured as a guest speaker alongside Google and Mayo Clinic leaders at Japan's largest pharmaceutical conference focused on agentic AI in clinical research.
  • AccenturecoreImplementation/ SI/ Consulting PartnerListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; supports enterprise consulting and implementation services alongside Medable's platform.
  • Syneos HealthcoreChannel Partner/ Reseller/ DistributorListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; CRO/biopharma services partner reselling and deploying Medable's digital trial platform.
  • CognizantcoreImplementation/ SI/ Consulting PartnerListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; IT services and consulting partner supporting enterprise deployments.
  • PwCcoreImplementation/ SI/ Consulting PartnerListed partner logo in Medable's Mid-to-Large Biopharma ecosystem network; consulting partner supporting strategy, validation, and enterprise adoption.
  • PPD (part of Thermo Fisher Scientific)coreChannel Partner/ Reseller/ DistributorTrusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.
  • ParexelcoreChannel Partner/ Reseller/ DistributorTrusted-by CRO partner logo on Medable's CRO Partner Program page; CRO channel reselling and deploying Medable's clinical trial platform to its sponsor clients.
  • Veeva SystemscoreTechnology or IntegrationPrebuilt MCP connector integration with Veeva (including Veeva Vault eTMF) listed as one of 30+ validated connectors that allow Medable agents to act across clinical and enterprise systems.
  • OraclecoreTechnology or IntegrationPrebuilt MCP connector integration with Oracle clinical systems as part of Medable's 30+ validated connector ecosystem, enabling agent interoperability.
  • MedidatacoreTechnology or IntegrationPrebuilt MCP connector integration with Medidata as part of Medable's 30+ validated connector ecosystem for EDC and clinical data interoperability.
  • Microsoft (MS 365)coreTechnology or IntegrationIntegration with Microsoft 365 collaboration tools (Teams) via Medable's MCP connectors so agents can surface insights and act across enterprise collaboration workflows.
  • SnowflakecoreTechnology or IntegrationPrebuilt connector to Snowflake as part of Medable's 30+ validated connectors, enabling clinical data interoperability across data warehouses.
  • OpenTextmoderateTechnology or IntegrationMedable's TMF Agent integrates with existing eTMF systems including OpenText to automate 95% of manual TMF document workflows.
  • SanofimoderateStrategic or Co-development PartnerFeatured in Medable's 'Sponsors talk AI' content series with Sanofi Global Head of Data Architecture, Utilization, and AI Engineering discussing AI integration in clinical trials and agentic AI adoption strategies.

Scale indicators21 records

Recent moves6 records

Expansion highlights7 records

Medable competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant life sciences cloud platform with Vault CTMS, eTMF, and eCDMS offerings that compete directly with Medable's clinical operations modules. Medable integrates with Veeva via MCP connectors, positioning it both as competitor and ecosystem partner.
  • Oracle Health Sciences (Clinical One): Incumbent EDC, CTMS, and randomization provider for large pharma and CROs, competing with Medable on unified trial platforms. Medable's MCP connector to Oracle clinical systems confirms its role as competitor and partner.
  • IQVIA: Largest CRO with proprietary clinical technology (Orchestrated Clinical Trials) and an AI-driven eCOA/DCT stack. Competes with Medable across CRO channel, eCOA, and DCT deployments for biopharma sponsors.

Direct peers

  • Medidata (Dassault Systèmes): Direct competitor in eCOA, EDC, and decentralized clinical trial technology, with Rave EDC and a broad sponsor/CRO install base. Medable's MCP connector to Medidata signals both direct competition and interoperability.
  • Science 37: Pioneer in decentralized clinical trial orchestration and direct competitor in DCT platform delivery for biopharma sponsors. Comparable in operating model as a DCT-native platform with eCOA, eConsent, and remote nurse capabilities.
  • Signant Health: Direct eCOA, eConsent, and patient engagement competitor formed by the merger of CRF Health and Bracket, serving the same top-tier biopharma and CRO customer base as Medable. Competes head-to-head in eCOA build libraries and translation capabilities.
  • Clario: Clinical trial endpoint technology provider offering eCOA, imaging, and cardiac safety solutions, with comparable device logistics and global trial expertise. Overlaps with Medable on eCOA, device provisioning, and regulatory-grade data capture.

Emerging players

  • ObvioHealth: DCT-focused clinical trial provider competing in decentralized trial design and eCOA, with stronger focus on fully decentralized operational delivery. Comparable in DCT-native positioning but smaller in eCOA library depth.
  • Castor: Cloud-native EDC and ePRO platform with growing DCT and eConsent capabilities, targeting emerging biopharma and academic sponsors. Competes with Medable in no-code study building and SMB-to-mid-market trial deployments.
  • Curebase: Decentralized clinical trial software platform with site network, competing in DCT delivery for sponsors seeking software-plus-operations offerings. Comparable in DCT-native thesis but smaller scale than Medable's global deployment footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks6 records

Key highlights6 records

Customer concentration

Medable social profiles

Digital presence

Medable compliance and trust

Trust signal

Compliance7 records

Medable financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medable leadership team

Management profile

Number of profiles

Profiles27 records

Medable funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medable M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medable

What does Medable do?

Medable sells a unified, cloud-agnostic clinical trial platform that combines eCOA+, eConsent (Total Consent), TeleVisit, BYOD/provisioned devices, sensors, and a no-code Study Studio, with an agentic AI layer (Agent Studio) of pre-built and custom AI agents for clinical monitoring, TMF, PI review, and digital data flow. The platform is purpose-built for decentralized clinical trials and sold primarily to biopharma sponsors and CROs.

Is Medable a public or private company?

Medable is a private company. It is classified as venture growth investor backed and is currently operating.

When was Medable founded?

Medable was founded in 2012. It employs 251 to 500 people.

Where is Medable based?

Medable is headquartered in Palo Alto, United States, in the North America region.

How does Medable make money?

Four revenue lines are on record. SaaS platform subscriptions (Agent Studio, eCOA+, Total Consent, Study Studio) is the primary driver. The others are device logistics and provisioning, professional services: Agentic Accelerator Program, integration, change management and data and evidence services (decentralized clinical trial data).

Who are Medable's main competitors?

Broad incumbents on record are Veeva Systems, Oracle Health Sciences (Clinical One) and IQVIA. Direct peers are Medidata (Dassault Systèmes), Science 37, Signant Health and Clario. Emerging players are ObvioHealth, Castor and Curebase.

Does Medable have an API?

Yes. Medable offers a cloud-agnostic API that integrates clinical and enterprise systems through MCP (Model Context Protocol) connectors and over 30 secure, validated connectors linking Veeva, Oracle, Medidata, MS 365, Snowflake, BigQuery, Salesforce, and collaboration stacks. Medable Agent Studio combines no-code agent creation with MCP connectors across clinical and enterprise systems to automate operational work while maintaining transparency, auditability, and regulatory alignment. Developer documentation is at www.medable.com/platform/agent-studio.

What industry is Medable in?

Medable's product category is Decentralized Clinical Trial Software Platform. Its primary akta.pro industry code is HLACAFAG, Medical-Grade Device Connectivity & Device Management (MDM), with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogMedable Expands Adoption of Agentic AI in Clinical Development with Alveus TherapeuticsMedable announced it is bringing agentic AI to Alveus Therapeutics, a clinical-stage biotech developing obesity and metabolic disease medicines. The Clinical Oversight Agent, built on Medable Agent Studio, connects to EDC, IRT, CTMS, and other systems to provide trial intelligence and recommend actions. Alveus is configuring the agent for its clinical oversight needs.BioXconomyAI Agent Boosts Drug Development ROI by 82xMedable Inc. announced its AI clinical monitoring agent can deliver net financial gains of up to $21 million per drug development program, with an 82x return on investment. The analysis, based on Tufts CSDD data, shows phase three trials yield $21 million in expected net present value gains and $5.6 million in direct operating cost reductions. Tufts and Medable will publish a peer-reviewed paper later this year.DrugdiscoverytrendsTufts model estimates 82x ROI and up to $21 million in value from Medable AI agentTufts Center for the Study of Drug Development and clinical trial platform Medable announced an analysis estimating Medable's Clinical Monitoring Agent could deliver an 82x ROI in phase 3 and 64x in phase 2 trials, roughly $21 million and $7.5 million in added value. Medable's agents require about 20% configuration and connect to roughly 40 systems, with a projected portfolio eNPV of up to $226 million for 20 indications and $565 million for 50.Mpo-magMedable Introduces Agentic Accelerator ProgramMedable Inc. launched its Agentic Accelerator Program to help life sciences companies adopt agentic AI for clinical development. The program offers onboarding, integration, governance, and change management support, with Medable Agent Studio deployed in nearly 400 trials across 70 countries.GenengnewsFinancial Value of AI Agents in Drug DevelopmentA Tufts Center for the Study of Drug Development analysis indicates that Medable's AI clinical monitoring agent can generate up to $21 million in net financial gains per drug development program. The study highlights an 82x return on investment and a 10-week acceleration in clinical trial timelines driven by operational efficiencies such as reduced on-site visits and faster patient enrollment.International Business TimesAI Could Cut 10 Weeks From Cancer Trials. Drugmakers Could Save Millions.A Tufts Center for the Study of Drug Development analysis indicates that AI agents can reduce late-stage cancer trial costs by up to $5.6 million and shorten development time by approximately 10 weeks. The study utilized Medable's clinical monitoring agent on an unspecified oncology program, demonstrating efficiencies in patient enrollment and data management. Industry leaders project these AI solutions could become standard in clinical trials within three to five years.FierceBiotechAI clinical monitoring agent can deliver up to 82 times the ROI in oncology: reportA Tufts Center for the Study of Drug Development analysis found that Medable’s AI clinical monitoring agent delivers up to 82 times ROI in oncology trials, generating net financial gains of up to $21 million per program. The tool accelerates development timelines by approximately 18 weeks through automated administrative tasks and improved enrollment efficiency. These efficiencies allow sponsors to realize revenue earlier and lower overall drug development costs.AxiosAI brings savings to clinical trials: studyA Tufts Center for the Study of Drug Development analysis found that AI agents can accelerate cancer drug clinical trials by approximately 10 weeks and reduce direct operating costs by up to $5.6 million in late-stage trials. The study applied a clinical monitoring agent from Medable to an unspecified oncology program, demonstrating efficiencies in patient enrollment and data interpretation. Industry officials project such AI tools could become standard features in clinical trials within three to five years.MorningstarNew Tufts CSDD Analysis Finds AI Agents Can Deliver Up to $21 Million in Net Financial Value Per Drug Development Program and Up to 82x ROITufts CSDD and Medable announced an analysis showing Medable's Clinical Monitoring Agent can deliver up to $21 million in net financial value per drug development program and an 82x ROI. The analysis found eNPV gains of $7.5 million in phase 2 trials and $11.3 million in combined phase 2 and 3 development. A peer-reviewed paper is expected later this year.BCC ResearchThe $1 Million Monthly Problem That AI Is Finally Solving in Clinical TrialsPharmaceutical companies spend approximately $1 million per month on average due to delays in clinical trial recruitment, with 80% of studies failing to meet enrollment deadlines. AI-powered systems are transforming decentralized clinical trials by improving patient matching, reducing dropout rates through behavioral analytics, and enabling remote monitoring with wearable devices and computer vision. Several AI-enabled clinical trial companies have attracted significant investment, with Medable raising over $500 million and Lindus Health securing $55 million in Series B funding this year.